Fan, Chengcheng
Wang, Xu
Zheng, Xiaoli
Sun, Yanan
Ye, Ke
Jiang, Yue
Liu, Xiao
Xu, Wencai
Liu, Yang
Yang, Yuanyuan
Liu, Jinsong
Jiang, Qiong
He, Chunyu
Wu, Xiaoyuan
Nie, Xin
Zhang, Jingwei
Tan, Bo
Wang, Wen
Zhang, Yougai
Feng, Zhuo
Yang, Chengliang
Lu, Yufei
Liu, Hailong
Chen, Xijuan
Xu, Jing
Liu, Fang
Zheng, Xuefeng
Wang, Jianhua
Wu, Shang
Chen, Guofu
Zhang, Yaowen
Jin, Linzhi
Ge, Hong
Funding for this research was provided by:
Health Commission of Henan Province (182106000062)
Article History
Received: 13 September 2023
Accepted: 13 February 2024
First Online: 7 March 2024
Declarations
:
: Our study was approved by the medical ethic committee of the Henan cancer hospital (2018087). The other two medical ethics committees of the participating centers also gave positive advice on the local feasibility of the trial. During the study, all modifications, extensions and updates of trial procedures should be reviewed and approved by the medical ethics committee in every participating center. Our study has been registered in the Chinese Clinical Trial registry (ChiCTR1800017646). Written informed consent will be obtained from all participants before randomization.
: Not applicable.
: The authors declare no competing interests.